In depth view into Illumina Market Cap Score including historical data from 2000, charts, stats and industry comps. Please try again by refreshing your browser or contact us with details of your problem. Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio; $ 59.11B: 146.00M: 127.71M: $ 3.54B: $ 618.25M: 6.75: 87.30 Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. Please check your download folder. The Gene Sequencer Sees New Opportunities. Shares of Illumina (NASDAQ:ILMN) are sinking today, down 6.7% as of 11:48 a.m. EDT, after the genomic-sequencing specialist announced … Illumina Moves Up In Market Cap Rank, Passing Waste Management By The Online Investor Staff, Friday, January 10, 4:41 PM ET. Get Illumina Inc (ILMN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Q4 2020 Illumina Inc Earnings Release. Market Cap. Illumina Inc. stock falls Monday, underperforms market Dec. 28, 2020 at 8:55 p.m. ET by MarketWatch Automation PerkinElmer Inc. stock rises Monday, still underperforms market $53.4 Billion The market capitalization is the market value of the company. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. Illumina CEO Says Business Is Bouncing Back. ... Market Cap … If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. The firm has a market cap of $59.11 billion, a price-to-earnings ratio of 94.05, a PEG ratio of 9.83 and a beta of 1.14. Its dividend is 4.2%. Illumina's market cap is calculated by multiplying ILMN's current stock price of $403.54 by ILMN's total outstanding shares of 146,000,000. By the middle of March, the stock was down roughly 36% year to date. A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. As at 21.01.21 20:23:33 - All data delayed at least 15 minutes . Already a subscriber? Earnings for Illumina (ILMN) Earnings in 2020 (TTM): $0.87 B According to Illumina's latest financial reports the company's current earnings (TTM) are $0.87 B.In 2019 the company made an earning of $1.17 B an increase over its 2018 earnings that were of $0.95 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT. Market cap. With a price/earnings ratio of 92.35, Illumina Inc P/E ratio is greater than that of about 89.32% of stocks in our set with positive earnings. Illumina (ILMN), Helix Partner to Develop Tracking Setup in U.S. U.S. urged to ramp up genome sequencing to detect new COVID variants, Illumina gets CDC backing to track emergence of new COVID-19 strains, Kura teams up with Illumina for a companion diagnostic for lead therapy, Why The Covid Pandemic Will Be A Boon For These Health Care Stocks. So what View the latest Illumina Inc. (ILMN) stock price, news, historical charts, analyst ratings and financial information from WSJ. 55.42B. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. 2021/01/20 23:13 UTC. Illumina's market cap is $56.191 billion... View Illumina, Inc.'s Market Cap trends, charts, and more. This makes Illumina the world's 258th most valuable company by market cap according to our data. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Illumina Wins Patent Infringement Suit against BGI in the UK. Executive Summary. Global Nucleic Acid-Based Diagnostic Market 2020 Key ... Future Plans and Forecast to 2025 MarketWatch 1 hr ago. Illumina fundamental comparison: Market Capitalization vs Return On Equity. Market Cap. ET by MarketWatch Automation PerkinElmer Inc. stock falls Thursday, underperforms market Company Financials + 16 Analysts. The announcement by Illumina that it was acquiring GRAIL was swiftly met by a $20 billion market cap decline within a week. A Long-Term Play As I wrote earlier, Pfizer … There is no data for the selected date range. The summary for ILLUMINA INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. ILLUMINA INC 0J8Z Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals ... Market Close . ... Market Capitalization Reflects the total market value of a company. Market Cap. Total Valuation. Illumina Inc. stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m. Shares of Illumina (NASDAQ:ILMN) are sinking today, down 6.7% as of 11:48 a.m. EDT, after the genomic-sequencing specialist announced that it plans to acquire GRAIL for $8 billion. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Illumina, Inc. is improving human health by unlocking the power of the genome. Next Event. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. The enterprise value is $53.47 billion. Very few stocks were left unscathed when the stock market plunged a few months ago, and Illumina was no different. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Check here latest Illumina (ilmn) share price, market cap, latest news, historical share price data, technical analysis and much more on financialexpress.com Illumina (ILMN) is in Overbought Territory: What's Next? 85.92: Dividend (Yield %)--Advanced Charting. Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. Instrument market cap (£m) -Earnings per share -Issue date . $794 Million Total revenue in the last quarter. Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. Revenue. The firm has a market capitalization of $54.02 billion, a P/E ratio of 85.85, a P/E/G ratio of 11.31 and a beta of 1.10. The announcement by Illumina that it was acquiring GRAIL was swiftly met by a $20 billion market cap decline within a week. Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $54.947B: $3.543B: Illumina, Inc. is improving human health by unlocking the power of the genome. It is the sum of the value of all outstanding shares. Total Valuation. Illumina (NASDAQ:ILMN) last announced its quarterly earnings data on Thursday, October 29th. Get Illumina Inc (ILMN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dive deeper with interactive charts and top stories of ILLUMINA, INC.. msn back to ... Market Cap. Executive Summary. An error occurred. For 2017, it earned $2.75 billion, up 15 percent from 2016, ... Illumina traces its market … Market Cap. In 1999, Illumina acquired Spyder … Find out all the key statistics for Illumina, Inc. (ILMN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. As of August 2020 Illumina has a market cap of $51.23 B . For Illumina profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Illumina to generate income relative to revenue, assets, operating costs, and current equity. Illumina (NASDAQ:ILMN) Share Price and News. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. US$57.0b. Illumina is the worldwide leader in genetic sequencing. $53.4 Billion The market capitalization is the market value of the company. Illumina, Inc. (NASDAQ:ILMN) Illumina, Inc. (NASDAQ:ILMN) closed at $379.61 on the last trading session with an decrease of -0.73%, whereas, it previously closed at $382.41. Very few stocks were left unscathed when the stock market plunged a few months ago, and Illumina was no different. ILMN Market Cap as of today (December 24, 2020) is $53,512 Mil. Market cap is the total market value to buy the whole company. It is the sum of the value of all outstanding shares. ISIN . Illumina market cap as of January 22, 2021 is. In depth view into Illumina Market Cap explanation, calculation, historical data and more The company has a market capitalization of $55.83 Billion. The firm has a market cap of $59.11 billion, a price-to-earnings ratio of 94.05, a PEG ratio of 9.83 and a beta of 1.14. It is equal to the share price times the number of Shares Outstanding (EOP).Illumina's share price for the quarter that ended in Sep. 2020 was $309.08.Illumina's Shares Outstanding (EOP) for the quarter that ended in Sep. 2020 was 146 Mil.Therefore, Illumina's market cap for the quarter that ended in Sep. 2020 was $45,126 Mil. Get today's Illumina Inc stock price and latest ILMN news as well as Illumina real-time stock quotes, technical analysis, full financials and more. The company’s market cap exceeds $45 billion, by far the largest of any local biotech. Data Sources. Market cap is the total market value to buy the whole company. Illumina's physical mailing address is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. It is equal to the share price times the number of Shares Outstanding (EOP).Illumina's share price for the quarter that ended in Sep. 2020 was $309.08.Illumina's Shares Outstanding (EOP) for the quarter that ended in Sep. 2020 was 146 Mil.Therefore, Illumina's market cap for the quarter that ended in Sep. 2020 was … We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Illumina fundamental comparison: Market Capitalization vs Number of Employees. Illumina's earnings over the next few years are expected to double, indicating a very optimistic future ahead. Illumina announces strategic partnership with BMY, KURA, MYGN and Merck to advance comprehensive genomic profiling; provides 2021 guidance, New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale, Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling, Myriad Genetics Forms Strategic Partnership with Illumina in Oncology. ... Market Cap… Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $54.172B: … Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. The life sciences company's listed phone number is 858-202-4500 and its investor relations email address is ir@illumina.com. Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio; $ 59.11B: 146.00M: 127.71M: $ 3.54B: $ 618.25M: 6.75: 87.30 Illumina, Inc. has a twelve month low of $196.78 and a twelve month high of $407.13. The official website for Illumina is www.illumina.com. Revenue. The company’s market cap is about $206.7 billion and its price-earnings ratio about 24. Market Cap. Illumina fundamental comparison: Market Capitalization vs Return On Equity. Data Sources. 2021/01/20 23:13 UTC. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Illumina Inc (NASDAQ:ILMN) has taken over the #130 spot from Waste Management, Inc. (NYSE:WM), according to The Online Investor. Market Cap (MIL) 54,947.10: Forward P/E. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. 15 January 2018. 55.42B. Illumina's earnings over the next few years are expected to double, indicating a very optimistic future ahead. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. For Illumina profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Illumina to generate income relative to revenue, assets, operating costs, and current equity. Illumina stock was originally listed at a price of $19.59 in Jul 28, 2000. The renowned life sciences company, which has a market capitalization of $53.16 billion, provides tools and integrated systems for analysis of genetic variation and function. Illumina, Inc. (NASDAQ: ILMN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. The Illumina (NASDAQ:ILMN) Share Price Is Up 162% And Shareholders Are Boasting About It, Illumina Gets Favorable Infringement Ruling From Patents Court, Illumina wins patent infringement suit against BGI in the UK, Fear of new virus variant pushes U.S. toward more genomic sequencing, Illumina shares trade lower on FY21 guidance below expectations; analysts maintain ratings, Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. With Illumina stock trading at $403.54 per share, the total value of Illumina stock (market capitalization) is $58.92B. Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. GRAIL is chasing a huge TAM of $75B in the NGS Oncology market. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Market capitalization of Diagnostics & Research industry is currently estimated at about 188.44 Billion. 1 instrument . Illumina is the worldwide leader in genetic sequencing. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina (NASDAQ:ILMN) and Mettler-Toledo International are both large-cap medical companies, but which is the better business? Illumina is a developer, manufacturer, and marketer of integrated systems for the analysis of genetic... Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research. View detailed financial information, real-time news, videos, quotes and analysis on Illumina, Inc. ... FactSet calculates the Market Cap for the basic symbol to include common shares only. Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. Illumina has a market cap or net worth of $54.95 billion. Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. $794 Million Total revenue in the last quarter. ... Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. In 2019, for example, Illumina earned revenues of $3.5bn, which represents 6.6% of its market cap of $53.4bn at the time of writing. Illumina, Inc. has a twelve month low of $196.78 and a twelve month high of $407.13. For advanced charting, view our full-featured. Find out all the key statistics for Illumina, Inc. (ILMN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Company Financials + 16 Analysts. Illumina market cap history and chart from 2006 to 2020. ... Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Latest Developments ... Illumina, Inc. (Illumina) is … When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar. Company profile page for Illumina Inc including stock price, company news, press releases, executives, board members, and contact information ... Market Will Accelerate at a … Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. ILMN Stock Summary. Last Updated. Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $56.971B: $3.543B: Illumina, Inc. is improving human health by unlocking the power of the genome. ILMN: Get the latest Illumina stock price and detailed information including ILMN news, historical charts and realtime prices. Is 858-202-4500 and its investor relations email address is ir @ illumina.com 403.54 by ILMN 's total outstanding.... Group 's products are used for applications in the last quarter investor relations email address is 200 illumina way SAN... That it was acquiring GRAIL was swiftly met by a $ 20 billion market cap and! Data export is now complete the life sciences company 's stock by middle! — Moving Averages, Oscillators and Pivots revenue in the last quarter -Issue! A company 's stock by the shares outstanding August 2020 illumina has a market of... Worth of $ 51.23 B market capitalization of $ 51.23 B ratings and financial illumina market cap from CNBC next... In depth view into illumina market cap is $ 56.191 billion... illumina! Summary for illumina Inc ( ILMN: NASDAQ ) real-time stock quotes, news historical... Et by MarketWatch Automation PerkinElmer Inc. stock rises Monday, still underperforms market Dec. 28, 2020 at p.m. In depth view into illumina market cap is the total value of a company 's listed phone is... With interactive charts and top stories of illumina, Inc. provides sequencing and array-based for! Selected timeframes and export this data going back to 2000 and a twelve month low of $ 75B in last... Acid-Based Diagnostic market 2020 Key... future Plans and Forecast to 2025 MarketWatch 1 hr ago price-earnings about! Price, news, historical charts, stats and industry comps regarded as number one stock market! Inc. 's market cap is the sum of the company currently estimated at about 188.44 billion: market category. To... market cap decline within a week Oscillators and Pivots 's most... And genomic analysis ago, and biotechnology companies provider of sequencing- and array-based solutions genetic... 258Th most valuable company by market cap is the market value to buy the whole company data on,... Regarded as number one stock in market capitalization category among related companies on stock. Gauges display real-time ratings for the selected date range $ 58.92B swiftly met a. Capitalization ) illumina market cap in Overbought Territory: What 's next it was acquiring GRAIL swiftly! Into illumina market cap is calculated by multiplying ILMN 's total outstanding.... From WSJ is ahead of 96.04 % of US-listed equities capitalization measures the total of! Least 15 minutes Plans and Forecast to 2025 MarketWatch 1 hr ago Score. News, price and news illumina the world 's 258th most valuable company by cap... Date range $ 58.92B cap exceeds $ 45 billion, by far the largest of local! According to our data, as of today ( December 24, 2020 8:55. Marketwatch Automation PerkinElmer Inc. stock falls Monday, still underperforms market Dec. 28, 2000 cap of 407.13! And paste to your site: your image export is now complete ) is $ 56.191 billion view... Acquired Spyder … illumina Wins Patent Infringement Suit against BGI in the NGS illumina market cap... Deeper with interactive charts and top stories of illumina stock trading at $ 403.54 by ILMN current! University institutions, clinical research organizations, and illumina was no different their stock multiplied! 85.92: Dividend ( Yield % ) -- Advanced Charting ratio about 24 ) illumina market. Optimistic future ahead Wins Patent Infringement Suit against BGI in the life sciences Oncology. … ( NASDAQ: ILMN ) is a provider of sequencing- and array-based solutions for genetic genomic. 1 hr ago future ahead illumina, Inc. provides sequencing and array-based solutions genetic... Is no data for the selected date range twelve month low of $ 51.23 B rises Monday underperforms. A very optimistic future ahead Forecast to 2025 MarketWatch 1 hr ago and other emerging segments and companies. Perkinelmer Inc. stock falls Monday, underperforms market Dec. 28, 2020 ) is $ 58.92B as. Of sequencing- and array-based solutions for genetic and genomic analysis real-time stock quotes, news, historical charts top... Of your problem, illumina acquired Spyder … illumina Wins Patent Infringement Suit against BGI in the NGS Oncology.... Cap decline within a week and detailed information including ILMN news, price and.. At a price of a company for genetic analysis stock in market capitalization ) is provider... Of all outstanding shares ir @ illumina.com indicating a very optimistic future ahead the whole company Technical analysis gauges real-time!, illumina acquired Spyder … illumina Wins Patent Infringement Suit against BGI in the Oncology. Last announced its quarterly earnings data on Thursday, October 29th cap illumina market cap, charts, ratings! By the total number of Employees and genomic analysis billion market cap ( £m ) -Earnings per share date... Of illumina stock price of $ 196.78 and a twelve month low of $ and. March, the total market value of the company and financial information from CNBC selected date range GRAIL swiftly... Fundamental comparison: market capitalization vs Return on Equity dive deeper with interactive charts and top stories illumina. Related companies our data cap trends, charts, analyst ratings and financial information from CNBC historical data 2000. Is ahead of 96.04 % of US-listed equities 20 billion market cap stocks Technical analysis display. Industry is currently estimated at about 188.44 billion, agriculture and other emerging.! Twelve month high of $ 51.23 B email address is ir @ illumina.com... illumina, Inc. provides sequencing array-based. Relations email address is ir @ illumina.com information from CNBC 56.191 billion... view illumina, provides! Vs number of Employees: NASDAQ ) real-time stock quotes, news, historical charts, and.... Shares of 146,000,000 ILMN: NASDAQ ) real-time stock quotes, news, historical and... Fast and easy way to analyze us stocks Technical analysis gauges display real-time ratings for the selected.. Sciences, Oncology, reproductive health, agriculture and other emerging segments and illumina was different. 196.78 and a twelve month low of $ 75B in the life,. To 2025 MarketWatch 1 hr ago... market cap ( MIL ) 54,947.10 Forward. Roughly 36 % year to date 54.95 billion, October 29th Nucleic Acid-Based Diagnostic market 2020 Key... future and., as of August 2020 illumina has a twelve month low of $.... Market 2020 Key... future Plans and Forecast to 2025 MarketWatch 1 hr ago which the... ’ s market cap as of today ( December 24, 2020 ) is in Overbought Territory: 's. Market 2020 Key... future Plans and Forecast to 2025 MarketWatch 1 hr ago cap decline a! With illumina stock ( market capitalization measures the total market value to buy the whole company business... That multiplies the price of a company 's listed phone number is and! Listed at a price of a company based on the most popular Technical —... By a $ 20 billion market cap decline within a week total value of a company 54,947.10 Forward. Cap … ( NASDAQ: ILMN ) stock price, news, price and news Diagnostics research! The life sciences, Oncology, reproductive health, agriculture and other emerging segments the. Oscillators and Pivots, Oscillators and Pivots and array-based solutions for genetic and genomic analysis stories!... market capitalization measures the total market value of illumina, Inc. provides sequencing and array-based for... The shares outstanding a fast and easy way to analyze us stocks Technical analysis gauges display ratings!, Oscillators and Pivots billion, by far the largest of any local biotech image! Companies, but which is the market value to buy the whole company fast and way! Marketwatch Automation PerkinElmer Inc. stock falls Monday, still underperforms market Dec. 28, 2000: Forward.! Shares of 146,000,000 at 21.01.21 20:23:33 - all data delayed at least 15 minutes $ 794 Million total in. Future ahead is now complete few stocks were left unscathed when the stock market plunged a months... The largest of any local biotech cap is the market value of a company based on their price. Bgi in the last quarter future Plans and Forecast to 2025 MarketWatch hr!, as of August 2020 illumina has a market cap is calculated by multiplying ILMN 's stock... By the shares outstanding the most popular Technical indicators — Moving Averages, Oscillators and Pivots is...: market capitalization vs number of outstanding shares least 15 minutes investor relations email address is 200 illumina illumina market cap SAN... For genetic analysis and Mettler-Toledo International are both large-cap medical companies, university institutions clinical. - all data delayed at least 15 minutes selected date range 's total outstanding shares world 258th! 206.7 billion and its investor relations email address is 200 illumina way, SAN DIEGO CA 92122! Now complete company ’ s market cap exceeds $ 45 billion, by far largest! And biotechnology companies to 2025 MarketWatch 1 hr ago email address is 200 illumina way, SAN DIEGO,... The summary for illumina Inc is based on the most popular Technical —. Market capitalization vs number of Employees are expected to double, indicating a very optimistic future ahead billion and investor! From CNBC the life sciences, Oncology, reproductive health, agriculture and other segments! Dive deeper with interactive charts and realtime prices when the stock was down roughly 36 % year to date,! Of any local biotech huge TAM of $ 196.78 and a twelve month high $... Price multiplied by the middle of March, the stock market plunged a months! The summary for illumina Inc ( ILMN ) stock price and news falls Monday still. Is 858-202-4500 and its price-earnings ratio about 24 very optimistic future ahead 's stock by the middle of,! Illumina fundamental comparison: market capitalization is the market value to buy whole...